[Herpes simplex virus, type II: microbiology and clinical experiences with attenuated vaccine].
D000328:Adult; D000818:Animals; D002642:Chick Embryo / Q000473:pathology; D046508:Culture Techniques; D005260:Female; D005827:Genetics, Microbial; D005831:Genital Diseases, Female / Q000209:etiology; D005832:Genital Diseases, Male / Q000209:etiology; D005860:Germany, West; D006561:Herpes Simplex / Q000453:epidemiology / Q000473:pathology / Q000517:prevention & control* / Q000628:therapy; D006801:Humans; D007115:Immunization Schedule; D007167:Immunotherapy; D008297:Male; D012008:Recurrence; D012703:Serotyping; D018139:Simplexvirus / Q000145:classification / Q000276:immunology* / Q000302:isolation & purification; D002583:Uterine Cervical Neoplasms / Q000209:etiology; D014613:Vaccines, Attenuated; D014765:Viral Vaccines
D014613:Vaccines, Attenuated; D014765:Viral Vaccines
Herpes simplex-Virus, Typ II: Mikrobiologie und klinische Erfahrungen mit einer abgetöteten Vaccine.